Weight-Control Compound Affects Obese and Lean Mice Differently

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


With obesity affecting an ever-increasing proportion of society, the search for fat-fighting drugs seems to have a heightened sense of urgency. Now a report published today in the Proceedings of the National Academy of Sciences provides interesting insight into one potential weight-control drug that affects obese mice differently than it does normal animals.

Daniel Lane of Johns Hopkins University School of Medicine and his colleagues worked with a compound called C75, which had previously been shown to suppress appetite and cause dramatic weight loss in mice after one injection by inhibiting the enzyme fatty acid synthase (FAS). Building on findings that showed C75 alters levels of brain messengers that regulate appetite, the team investigated how mice responded to the compound over a five-day period. They found that C75 suppressed the appetite of both lean and obese mice on the first day it was administered. In subsequent days, however, the two types of mice showed dramatically different responses to the molecule. Whereas obese mice ate 90 percent less than their normal food intake for the entire five-day period, the lean mice returned to their regular eating patterns on the second day. "The results, Lane says, "suggest that being at a normal weight gives mice the ability to become quickly insensitive to the compound."

Moreover, when compared with mice eating the same number of calories, C75-treated animals lost more weight. Because animals must burn more calories than they consume in order to lose weight, the researchers propose that C75 might also increase energy expenditure of the mice, in addition to controlling their appetites. Though the implications for humans are still unclear, Lane suggests that scientists "are closing in on a powerful biological signal in weight control."

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe